Skip to main content
Terumo Interventional Systems
 Terumo Group
Contact us
English
Español

  

  • Products

      Products

    • Specialties
      • Interventional Cardiology
      • Interventional Oncology
      • Peripheral Intervention
    • Solutions
      • TRI - Transradial Intervention
      • R2V™ - Radial to Visceral
    • Procedures
      • Access
      • TLA - Therapeutic Lesion Access
      • Imaging
      • Therapeutic
      • Closure
    • Categories
    • All Products
  • Featured Topics

      Featured Topics

    • Radial First
      • TRI - Transradial Intervention
      • R2V™ - Radial to Visceral
    • Ultimaster
    • TLA - Therapeutic Lesion Access
    • CCR
  • Clinical Evidence
  • Video Library
  • Education & Training
  • About Us

      About Us

    • TIS History
    • Who We Are
    • TIS Global Network
    • Company Profile
    • Our Brand Story
  • News & Events

      News & Events

    • News
    • Events
 Terumo Group
Contact us
English
Español

  

  1. Home
  2. Featured Topics
  3. R2V™ - Radial to Visceral
To see the information that are approved in your region, please choose the relevant country or region below.
openclose
To see the information that are approved in your region, please choose the relevant country or region below.
openclose
Disclaimer
Please be aware that this website is developed, controlled, and operated as an educational and informational site for Healthcare Professionals and in no event directed to the general public. Also please be aware that a reference to a product or service on this website does not imply that such product or service is or will be available in your country or region of the world where it may be subject to different regulations and conditions of use. You should always rely on product information especially created for your country. If necessary, please contact your local Terumo affiliate to obtain the appropriate product information for your country.
Your use of this Website is governed by the “Terms of Use” and the “Privacy Policy”, and you are strongly advised to read the Terms of Use and the Privacy Policy carefully before any further use of the Website. If you cannot accept the Terms of Use and the Privacy Policy, please exit this Website.
Note: This Website is not intended to be reviewed by residents of following countries and areas. If you are a resident of any of these, please access the relevant website: United States, Canada, Europe, Middle East and Africa, LATAM, Australia and New Zealand, Thailand, Japan, and China.
Accept Decline

How to start R2V™

Learning Radial Approach

Why is there need R2V™ (Radial to Visceral )

Radial to Visceral (R2V™) intervention brings various benefits over Transfemoral Artery Access (TFA), including reduced bleeding complications, easy access site management,
improved patient satisfaction and the opportunity for same day discharge. Terumo offers various access devices and embolic agents for R2V™.1-7

Benefit of R2V™

  • ReduceProcedural Complications

    • Less bleeding complications at the access site
    • Low risk for stroke
    • No reliance on internal closure device
  • Treat More Patients

    • Easier access site management
    • Reach visceral anatomy and beyond with longer access products
    • Patient-preferred
  • Increase Efficiency

    • Allows for same-day-discharge
    • Reduce costs and improve procedure time
    • Ease of access to vessel origins from above

Expected Concern and Solutions

  • Vessel access

    01

  • Catheter insertion

    02

  • Approach to visceral

    03

  • Embolization

    04

  • Hemostasis

    05

step01

Vessel Access

Vessel Access (image)

Expected Concern

  • Puncture failure due to the small vessel
  • Radial spasm
  • Radial artery occlusion due to the vessel damage caused by device insertion

Solution

  • Use a thin-wall introducer sheath
  • Use a hydrophilic coated introducer sheath
  • Video lecture
    How to puncture
  • Knowledge
    2 types of puncture method with proper needle
  • Evidence
    Ultrasound guided puncture
Featured Products
  • Glidesheath Slender (image)
    Glidesheath Slender™
  • RADIFOCUS™ Introducer II Mcoat™ (image)
    RADIFOCUS™ Introducer II Mcoat™

step02

Catheter Insertion

Catheter Insertion (image)

Expected Concern

  • Insufficient torque to change catheter tip direction
  • Insufficient length for distal delivery

Solution

  • Double braided Glidecath provides excellent torque control
  • Provides excellent trackability through catheter flexibility and Terumo’s M-coat
Featured Products
  • RADIFOCUS Glidecath R.A.V.I. MG1/MG2 shape (image)
    RADIFOCUS™ Glidecath™R.A.V.I. MG1/MG2
  • RADIFOCUS Guide Wire M (image)
    RADIFOCUS™ Guide Wire M

step03

Approach to Visceral

Access to Visceral (image)

Expected Concern

  • Difficulty in branch selectivity at bifurcations

Solution

  • Option to use Progreatλ, a microcatheter which excels in branch selectivity
  • Knowledge
    Features of Progreatλ
Featured Products
  • RADIFOCUS Guide Wire GT with gold coil (image)
    RADIFOCUS™ Guide Wire GT with gold coil
  • Progreat λ (image)
    Progreat λ™
  • Occlusafe (image)
    Occlusafe™

step04

Hemostasis

Hemostasis (image)

Expected Concern

  • Radial artery occlusion caused by prolonged high-pressure hemostasis

Solution

  • Video lecture
    How to get patent hemostasis
  • Knowledge
    Introduction some protocols of patent hemostasis
  • Evidence
    Reduction of RAO rate with patient hemostasis
Featured Products
  • TR Band (image)
    TR Band™

APAC forum on R2V™

featured_radial_to_visceral_topics_apac2021_forum_1_800x494.png
APAC forum on R2V™ - How to start R2V™ successfully? -
featured_radial_to_visceral_topics_apac2021_forum_2_800x494.png
APAC forum on R2V™ - Why is there a need for R2V™ -
featured_radial_to_visceral_topics_apac2023_forum_800x494.png
APAC forum on R2V™ - Complex &Complications -

Latest Topics

March 07, 2023

Prospective, Multi-Center, Registry Study of Radial Access Embolization Procedures: 30 Day Outcomes

A prospective registry on 30-day outcomes with 12 month follow up was conducted to increase the data available on radial access in visceral interventions (RAVI) and to show that radial access is safe and feasible for a wide range of embolization procedures.

How can we assist you?

At Terumo Interventional Systems, we don’t just deliver quality medical products – we offer the necessary resources and support to help you use them to their full potential. Contact us today for any assistance you may need.

Contact Us
Pattern (image)
Terumo Interventional Systems
 
Top
  • Products
    • Specialties
      • Interventional Cardiology
      • Interventional Oncology
      • Peripheral Intervention
    • Solutions
      • TRI - Transradial Intervention
      • R2V™ - Radial to Visceral
    • Procedures
      • Access
      • TLA - Therapeutic Lesion Access
      • Imaging
      • Therapeutic
      • Closure
    • Categories
    • All Products
  • Featured Topics
    • Radial First
      • TRI - Transradial Intervention
      • R2V™ - Radial to Visceral
    • Ultimaster
    • TLA - Therapeutic Lesion Access
    • CCR
  • Clinical Evidence
  • Video Library
  • Education & Training
  • About Us
    • TIS History
    • Who We Are
    • TIS Global Network
    • Company Profile
    • Our Brand Story
  • News & Events
    • News
    • Events
 Newsletter
 
  1. Home
  2. Featured Topics
  3. R2V™ - Radial to Visceral
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Cookie Policy
  • Social Media Policy
  • Site Map
  • Contact Us

All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties.